These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Cannabinoid receptors as therapeutic targets in the management of liver diseases. Mallat A; Lotersztajn S Drug News Perspect; 2008 Sep; 21(7):363-8. PubMed ID: 19259549 [TBL] [Abstract][Full Text] [Related]
7. Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management. Ginès P; Guevara M Hepatology; 2008 Sep; 48(3):1002-10. PubMed ID: 18671303 [TBL] [Abstract][Full Text] [Related]
8. A review of the natural history of chronic hepatitis B in the era of transient elastography. Chan HL; Wong GL; Wong VW Antivir Ther; 2009; 14(4):489-99. PubMed ID: 19578234 [TBL] [Abstract][Full Text] [Related]
9. Have hematopoietic growth factors made an impact on the management of liver disease? Tyagi P; Madan K Trop Gastroenterol; 2008; 29(4):187-93. PubMed ID: 19323086 [TBL] [Abstract][Full Text] [Related]
10. [Therapy with immunosuppressive agents in hepatology]. Kleine FD; Keitel W; Franke A Z Gesamte Inn Med; 1969 Jun; 24(12):372-7. PubMed ID: 5404297 [No Abstract] [Full Text] [Related]
11. [Hepatology at the turn of centuries]. Nogaller AM Klin Med (Mosk); 2002; 80(9):13-7. PubMed ID: 12416218 [TBL] [Abstract][Full Text] [Related]
15. Role of vaptans in the management of hydroelectrolytic imbalance in liver cirrhosis. Facciorusso A; Amoruso A; Neve V; Antonino M; Prete VD; Barone M World J Hepatol; 2014 Nov; 6(11):793-9. PubMed ID: 25429317 [TBL] [Abstract][Full Text] [Related]
16. Ascites and spontaneous bacterial peritonitis: an Asian perspective. Lee JM; Han KH; Ahn SH J Gastroenterol Hepatol; 2009 Sep; 24(9):1494-503. PubMed ID: 19743995 [TBL] [Abstract][Full Text] [Related]
17. Development of thrombopoietin receptor agonists for clinical use. Ikeda Y; Miyakawa Y J Thromb Haemost; 2009 Jul; 7 Suppl 1():239-44. PubMed ID: 19630808 [TBL] [Abstract][Full Text] [Related]
19. Current clinical care compared with new Dutch guidelines for hepatitis C treatment. Slavenburg S; Lamers MH; Roomer R; de Knegt RJ; van Oijen MG; Drenth JP Neth J Med; 2009 May; 67(5):177-81. PubMed ID: 19581667 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of serum percent trisialotransferrin as potential predictive biomarker of hepatocellular dedifferentiation in chronic liver disease. Gressner OA; Jafari S; Erkens M; Gao C; Stanzel S; Gressner AM Clin Chim Acta; 2009 May; 403(1-2):188-93. PubMed ID: 19281805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]